You are here!
In the city of Milan
With experts in biomaterials development for healthcare and aesthetic products
Welcome to BMG Pharma
BMG is a cutting-edge company with years of experience in the development and international partnership of biopharmaceutical products.

We believe that transparency
is a fundamental value.


PR FESR 2021-27 – Research and Development Call 2022
DEVELOPMENT OF INNOVATIVE BIOMATERIALS USEFUL IN REGENERATIVE MEDICINE BASED ON BIOCOMPATIBLE DERIVATIVES OF SODIUM HYALURONATE WITH BIOLOGICALLY ACTIVE FUNCTIONS. Beneficiary: BMG Pharma® SpA Eligible expenditure: 739.625,51 Euro Grant granted: 313.899,64 Euro ...
The latest news

BMG Pharma: leadership in the Oral Care and Aesthetic Medicine sector
The double soul of BMG Pharma and our future challenges

BMG Pharma: innovation, research, growth and commitment to the future
A great success for BMG Pharma News!

Mastrodonato (BMG Pharma): without innovation you cannot be successful
Are you interested in knowing the point of view of our founder and CEO Marco Mastrodonato about how to do pharmaceutical entrepreneurship?
Read his interview on Caltalks:
“Thinking outside the box”, innovation as secret of the success.
BMG Pharma performs the concept of innovation in the biotech sector, relying on chemical structure modification of biotechnological origin for the development of new chemical entities and improving their functions and efficacy, differentiating itself from all competitors on the market. “Our strategy,” Mastrodonato continues, “is to develop biotechnology products covering both aesthetic dermatology and osteoarthritis.”
In BMG Pharma we find not limits, but solutions, the company wants to be present in the market bringing new products based on science and aligning itself with an evolving context, trying to deliver in the hands of the physician something truly innovative, interactive, and effective to propose to the patient.
To read the whole interview, click here: https://www.caltalks.com/2023/11/mastrodonato-bmg-pharma-senza.html
The latest news

PR FESR 2021-27 – Research and Development Call 2022
DEVELOPMENT OF INNOVATIVE BIOMATERIALS USEFUL IN REGENERATIVE MEDICINE BASED ON BIOCOMPATIBLE DERIVATIVES OF SODIUM HYALURONATE WITH BIOLOGICALLY ACTIVE FUNCTIONS. Beneficiary: BMG Pharma® SpA Eligible expenditure: 739.625,51 Euro Grant granted: 313.899,64 Euro ...

BMG Pharma: leadership in the Oral Care and Aesthetic Medicine sector
The double soul of BMG Pharma and our future challenges

BMG Pharma: innovation, research, growth and commitment to the future
A great success for BMG Pharma News!

Mastrodonato (BMG Pharma): without innovation you cannot be successful
Are you interested in knowing the point of view of our founder and CEO Marco Mastrodonato about how to do pharmaceutical entrepreneurship?
Read his interview on Caltalks:
“Thinking outside the box”, innovation as secret of the success.
BMG Pharma performs the concept of innovation in the biotech sector, relying on chemical structure modification of biotechnological origin for the development of new chemical entities and improving their functions and efficacy, differentiating itself from all competitors on the market. “Our strategy,” Mastrodonato continues, “is to develop biotechnology products covering both aesthetic dermatology and osteoarthritis.”
In BMG Pharma we find not limits, but solutions, the company wants to be present in the market bringing new products based on science and aligning itself with an evolving context, trying to deliver in the hands of the physician something truly innovative, interactive, and effective to propose to the patient.
To read the whole interview, click here: https://www.caltalks.com/2023/11/mastrodonato-bmg-pharma-senza.html